Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Receivables - Other (2019 - 2025)

Historic Receivables - Other for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to $908000.0.

  • Pliant Therapeutics' Receivables - Other fell 5904.38% to $908000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $908000.0, marking a year-over-year decrease of 5904.38%. This contributed to the annual value of $2.3 million for FY2024, which is 2318.99% down from last year.
  • Latest data reveals that Pliant Therapeutics reported Receivables - Other of $908000.0 as of Q3 2025, which was down 5904.38% from $1.5 million recorded in Q2 2025.
  • Over the past 5 years, Pliant Therapeutics' Receivables - Other peaked at $3.0 million during Q4 2023, and registered a low of $320000.0 during Q2 2022.
  • In the last 5 years, Pliant Therapeutics' Receivables - Other had a median value of $1.6 million in 2025 and averaged $1.6 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first crashed by 9586.02% in 2021, then surged by 63906.25% in 2023.
  • Over the past 5 years, Pliant Therapeutics' Receivables - Other (Quarter) stood at $385000.0 in 2021, then soared by 180.0% to $1.1 million in 2022, then surged by 178.01% to $3.0 million in 2023, then dropped by 23.19% to $2.3 million in 2024, then tumbled by 60.56% to $908000.0 in 2025.
  • Its Receivables - Other stands at $908000.0 for Q3 2025, versus $1.5 million for Q2 2025 and $1.7 million for Q1 2025.